SENATE BILL No. 625

 

 

December 1, 2015, Introduced by Senators HANSEN, GREEN, COLBECK, JONES, BIEDA, YOUNG, WARREN, PROOS, KNOLLENBERG, BOOHER, HILDENBRAND, MARLEAU and HERTEL and referred to the Committee on Insurance.

 

 

 

     A bill to amend 1956 PA 218, entitled

 

"The insurance code of 1956,"

 

(MCL 500.100 to 500.8302) by adding section 3406t.

 

THE PEOPLE OF THE STATE OF MICHIGAN ENACT:

 

     Sec. 3406t. (1) An expense-incurred hospital, medical, or

 

surgical policy or certificate delivered, issued for delivery, or

 

renewed in this state and a health maintenance organization group

 

or individual contract that provides coverage for prescribed orally

 

administered anticancer medications and intravenously administered

 

or injected anticancer medications must ensure both of the

 

following:

 

     (a) That financial requirements applicable to prescribed

 

orally administered anticancer medications are no more restrictive

 


than the financial requirements applied to intravenously

 

administered or injected anticancer medications that are covered by

 

the policy, certificate, or contract and that there are no separate

 

cost-sharing requirements that are applicable only to prescribed

 

orally administered anticancer medications.

 

     (b) That treatment limitations applicable to prescribed orally

 

administered anticancer medications are no more restrictive than

 

the treatment limitations applied to intravenously administered or

 

injected anticancer medications that are covered by the policy,

 

certificate, or contract and that there are no separate treatment

 

limitations that are applicable only to prescribed orally

 

administered anticancer medications.

 

     (2) An insurer or health maintenance organization cannot

 

achieve compliance with this section by increasing financial

 

requirements, reclassifying benefits with respect to anticancer

 

medications, or imposing more restrictive treatment limitations on

 

prescribed orally administered anticancer medications or

 

intravenously administered or injected anticancer medications

 

covered under the policy, certificate, or contract on the effective

 

date of the amendatory act that added this section.

 

     (3) As used in this section:

 

     (a) "Anticancer medication" means a medication used to kill,

 

slow, or prevent the growth of cancerous cells.

 

     (b) "Financial requirement" means deductibles, copayments,

 

coinsurance, out-of-pocket expenses, aggregate lifetime limits, and

 

annual limits.

 

     (c) "Treatment limitation" means limits on the frequency of

 


treatment, days of coverage, or other similar limits on the scope

 

or duration of treatment.